Development and evaluation of a training program to foster the use of written drug information in community pharmacies. Part 2: evaluation
Keywords:Educational program, pharmacists, written medicine information, evaluation, patient information
Objective: To evaluate two educational interventions to foster the use of standardised written patient information (consumer medicine information, CMI).
Methods: A quasi-experimental, repeated measures design was selected to evaluate the impact of the interventions (written protocol only; workshop with follow-up training). Pharmacies were recruited into three groups: control (n = 9), protocol (n = 9) and workshop (n = 6). Pharmacists collected data on CMI provision and use in verbal counselling over a 3-day period at three time points: baseline (prior to commencement of study), post-box (after a box of CMI was provided to protocol and workshop groups) and post-intervention (after delivery of interventions to protocol and workshop groups). Repeated measures ANOVA was used to compare the mean rates of CMI provision and use.
Results: Data were collected for 608 prescription items. There were no significant changes in rates of CMI provision in the three groups. Protocol and workshop groups demonstrated an increase in the mean rates of CMI use in counselling. The workshop group demonstrated significant increases in the mean rates of CMI use with time, compared to protocol (F(2,26) = 5.80, p < 0.01) and control groups (F(2,26) = 3.99, p = 0.03).
Conclusions: The more intensive educational program led to increased use of CMIs in verbal counselling.
Al-Saffar, N., Deshmukh, A., Carter, P., & Adib, S. (2005). Effect of information leaflets and counselling on antidepressant adher- ence: Open randomised controlled trial in a psychiatric hospital in Kuwait. International Journal of Pharmacy Practice, 13(2), 123 – 131.
Aslani, P., Benrimoj, S. I., & Krass, I. (2006). Development and evaluation of a training program to foster the use of written drug information in community pharmacies- part 1- development. Pharmacy Education, 6(1), 41–52.
Baker, S. J. (1997). Who can read consumer product information? Australian Journal of Hospital Pharmacy, 27(2), 126–131.
Benrimoj, S. I., Berry, G., Collins, D., Lauchlan, R., & Stewart, K. (1997). A randomised trial on the effect of education and a professional allowance on clinical intervention rates in pharmacy: Clinical and cost evaluation. Sydney: University of Sydney.
Berardo, D. H., Kimberlin, C. L., & Barnett, C. W. (1989). Observational research on patient education activities of community pharmacists. Journal of Social and Administrative Pharmacy, 6(1), 21–30.
Blaikie, L. (1999). Pharmacist intervention improves antibiotic compliance. New Zealand Pharmacy, 19, 32–33.
Buchbinder, R., Hall, S., Grant, G., Mylvaganam, A., & Patrick, M. (2001). Readability and content of supplementary written drug information for patients used by Australian rheumatologists. Medical Journal of Australia, 174(11), 575–578.
Caleo, S. (1995). An economic analysis of pharmacists’ clinical and administrative interventions associated with the pharmaceutical benefits scheme. Unpublished Graduate Diploma of Science, University of Sydney.
Campagna, K. D., & Newlin, M. H. (1997). Key factors influencing pharmacists’ drug therapy decisions. American Journal of Health-System Pharmacy, 54, 1307–1313.
Culbertson, V. L., Arthur, T. G., Rhodes, P. J., & Rhodes, R. S. (1988). Consumer preferences for verbal and written medication information. Drug Intelligence and Clinical Pharmacy, 22, 390 – 396.
Dickinson, D., Raynor, D., & Duman, M. (2001). Patient information leaflets for medicines: Using consumer testing to determine the most effective design. Patient Education and Counseling, 43(2), 147–159.
Dolinsky, D., & Sogol, E. (1989). The patient package insert and the pharmacists role. In M. Bogaert, R. Vander Stichele, J. -M. Kaufman, & R. Lefebvre (Eds.), Patient package insert as a source of drug information- proceedings of an international symposium on patient package inserts as a source of drug information, Gent, Belgium, 26 – 28 September 1988 (pp. 27 – 37). Amsterdam: Elsevier Science.
Foster, D., & Rhoney, D. (2002). Readability of printed patient information for epileptic patients. Annals of Pharmacotherapy, 36(12), 1856–1861.
Gotsch, A. R., & Liguori, S. (1982). Knowledge, attitude, and compliance dimensions of antibiotic therapy with PPIs. Medical Care, 20(6), 581–595.
Herrier, R. (1994). Why aren’t more pharmacists counseling? American Pharmacy, NS34(11), 22–23.
Honey, P., & Mumford, A. (1992). The manual of learning styles, 3rd ed. Maidenhead: P. Honey.
Knapp, D. A. (1979). Barriers faced by pharmacists when attempting to maximize their contribution to society. American Journal of Pharmaceutical Education, 43, 357–359.
Koo, M., Krass, I., & Aslani, P. (2002). Consumer opinions on medicines information and factors affecting its use—an Australian experience. International Journal of Pharmacy Practice, 10, 107–114.
Koo, M., Krass, I., & Aslani, P. (2003). Factors influencing consumer use of written drug information. Annals of Pharma- cotherapy, 37, 259–267.
Koo, M., Krass, I., & Aslani, P. (2005). Patient characteristics influencing evaluation of written medicine information: Lessons for patient education. Annals of Pharmacotherapy, 39, 1434 – 1440.
Koo, M., Krass, I., & Aslani, P. (2006). Enhancing patient education about medicines: Factors influencing reading and seeking of written medicine information. Health Expectations, 9, 174 – 187.
Lewis, R. K., Lasack, N. L., Lambert, B. L., & Connor, S. E. (1997). Patient counseling—A focus on maintenance therapy. American Journal of Health-System Pharmacy, 54, 2084–2097.
Livingstone, C. R., Pugh, A. L. G., Winn, S., & Williamson, V. K. (1996). Developing community pharmacy services wanted by local people: Information and advice about prescription medicines. International Journal of Pharmacy Practice, 4, 94–102.
Machuca, M., Espejo, J., Gutierrez, L., Machuca, M., & Herrera, J. (2003). The effect of written information provided by pharmacists on compliance with antibiotherapy. Ars Pharmaceu- tica, 44(2), 141–157.
Morris, L. A., & Halperin, J. A. (1979). Effects of written drug information on patient knowledge and compliance: A literature review. American Journal of Public Health, 69(1), 47–52.
Morrow, N., & Hargie, O. (1992). Patient counselling: An investigation of core situations and difficulties in pharmacy practice. International Journal of Pharmacy Practice, 1, 202–205.
Myers, E. D., & Calvert, E. J. (1984). Information, compliance and side effects: A study of patients on antidepressant medication. British Journal of Clinical Pharmacology, 17, 21–25.
Norusis, M. J. (1997). SPSS professional statisticse 7.5. Chicago: SPSS Inc.
Peura, S., Klaukka, T., Hannula, A. M., & Eerikainen, S. (1993). Electronically produced information leaflets increase patients’ understanding of antibiotics. International Journal of Pharmacy Practice, 2, 22–25.
Raynor, D., & Knapp, P. (2000). Do patients see, read and retain the new mandatory medicines information leaflets? Pharmaceutical Journal, 264, 268–270.
Raynor, D., Savage, I., Knapp, P., & Henley, J. (2004). We are the experts: People with asthma talk about their medicine information needs. Patient Education and Counseling, 53(2), 167 – 174.
Raynor, D., Knapp, P., Moody, A., & Young, R. (2005). Patient information leaflets- impact of European regulations on safe and effective use of medicines. Pharmaceutical Journal, 275, 609 – 611.
Savage, I. (1997). Time for prescription and OTC advice in independent community practice. Pharmaceutical Journal, 258, 873–877.
Schommer, J. C. (1995). Higher levels of consultation services increase patient satisfaction. American Pharmacy, NS35(8), 33–39.
Schommer, J., & Wiederholt, J. (1994). Pharmacists’ perceptions of patients’ needs for counseling. American Journal of Hospital Pharmacy, 51, 478–485.
Schommer, J., & Wiederholt, J. (1995). A field investigation of participant and environment effects on pharmacist-patient communication in community pharmacies. Medical Care, 33(6), 567–584.
Sleath, B., & Wurst, K. (2002). Patient receipt of, and preferences for receiving, antidepressant information. International Journal of Pharmacy Practice, 10(4), 235–242.
Therapeutic Goods Regulations. (1993a). Part 2A—patient information, regulation 9A.
Therapeutic Goods Regulations. (1993b). Schedule 12—patient information documents.
Venkataraman, K., Madhavan, S., & Bone, P. (1997). Barriers and facilitators to pharmaceutical care in rural community practice. Journal of Social and Administrative Pharmacy, 14(4), 208–219.
Windows. (1997). Statistical package for the social sciences (version 7.5.2). Chicago: SPSS Inc.
Windsor, R. A., Baranowski, T., Clark, N., & Cutter, G. (1984). An introduction to evaluation. In Evaluation of health promotion and education programs (pp. 1 – 20). Mountain View: Mayfield Publishing Company.